Medical group said key elements well woman exams

Tuesday, 24 July, HealthDay News)--the latest guidelines for cervical cancer screening say that most women don't need annual Pap smears, but they still need yearly exams well woman with their obstetrician/gynecologist, according to the American College of Obstetricians and Gynecologists (ACOG).

In the opinion of the Committee, released Monday, the College outlines when women should undergo pelvic exams, which women need clinical examination of mammary glands and why the Bureau visit the annual well woman is important.

Annual well woman exam is an opportunity for doctors to advise patients about following a healthy lifestyle and reducing health risks. The trip includes a physical exam that assesses general health, including blood pressure and weight.

A pelvic exam is a common part of the visit, the OB-GYN and includes three parts: external examination, an internal exam and exam mirror internal/external keyboard, according to the press release of the APS. Women should begin annual pelvic exams are held at the age of 21.

Young women do not have to pass an internal examination, if they do not have signs of menstrual disorders, vaginal discharge, pelvic pain or other symptoms related to reproductive, said College.

Screening for sexually transmitted infections can be done using urine or vaginal tampons without an internal exam.

Another important part of the visit, the good woman is a clinical breast exam. This should be done every one to three years for women aged 20 to 39, according to ACOG and other groups, health/medical. Women aged 40 years and older must have annual mammograms and clinical breast exams annually, ACOG recommends.

Decisions on the appropriateness of the internal pelvic exam breast exams or should always be with the consent of the patient, "said ACOG.

In the August issue of the journal obstetrics and Gynecology & appears in the Committee's opinion.

--Robert Preidt Copyright © 2012 HealthDay. All rights reserved. Source: American College of Obstetricians and Gynecologists, press release, July 23, 2012

View the original article here

When gender matters: Restless legs syndrome. Report of the “RLS and woman” workshop endorsed by the European RLS Study Group

Mauro Manconia, , , Jan Ulfbergb, Klaus Bergerc, Imad Ghorayebd, Jan Wesströme, Stephany Fuldaf, Richard P. Alleng, Thomas Pollmächerf, ha Sleep and Epilepsy Center, Neurocenter (EOC) of Southern Switzerland, Civic Hospital, Lugano, Via Tesserete 46, 6900 Lugano, Switzerlandb Department of Medicine, Uppsala University, Uppsala, Swedenc Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germanyd Clinical Neurophysiology Department, Centre Hospitalier et Universitaire de Bordeaux, Bordeaux cedex, Francee Center for Clinical Research Dalarna, Department of Women's and Children's Health, Uppsala University, Swedenf Max Planck Institute of Psychiatry, Munich, Germanyg Center of Mental Health, Klinikum Ingolstadt, Ingolstadt, Germanyh Department of Neurology, Johns Hopkins University, Bayview Medical Center, Baltimore, MD, USAReceived 13 May 2011. Revised 30 August 2011. Accepted 30 August 2011. Available online 9 November 2011.View full text Sleep is an essential human behavior that shows prominent gender differences. Disturbed sleep, in particular, is much more prevalent in females than males. Restless legs syndrome (RLS) as one cause of disturbed sleep was observed to be somewhat more common among women than men in Ekbom's 1945 seminal series of clinical cases with the disease. He, however, reported this gender difference mainly for those with more severe symptoms. Since then numerous studies have reported that women are affected by RLS about twice as often as males for mild as well as moderate to severe RLS. The present review focuses on RLS in females from the perspectives of both epidemiology and pathophysiology. RLS will generally become worse or might appear for the first time during pregnancy. Parity increases the risk of RLS later in life suggesting that pregnancy is a specific behavioral risk factor for developing RLS. Some evidence suggests that dysfunction in iron metabolism and high estrogen levels might contribute to RLS during pregnancy. But, menopause does not lower the incidence of RLS nor does hormone replacement therapy lead to an increase, suggesting a quite complex uncertain role of hormones in the pathophysiology of RLS. Therefore, further, preferably longitudinal studies are needed to unravel the factors causing RLS in women. These studies should include genetic, clinical and polysomnographic variables, as well as hormonal measures and variables assessing iron metabolism.

prs.rt("abs_end");Restless legs syndrome; Gender; Female; Sleep; Insomnia; Pregnancy; Estrogens; Menopause; Quality of life

Figures and tables from this article:

Fig. 1. Epidemiological results on RLS and pregnancy. Histograms show the prevalence trend of RLS in a group of 606 women surveyed at the end of pregnancy. In the period before pregnancy, 60 women already experienced RLS symptoms in their life (in a non pregnancy period) and were classified as “pre-existing RLS”. The remaining 546 women had never experienced RLS symptoms before and were classified as “healthy”. During the first assessed pregnancy (2nd histogram) 101 women, out of the 546 “healthy” ones, developed a transient RLS form strictly related to the pregnancy and were classified as “pregnancy-related RLS”. All these 101 women with a new form of pregnancy-related RLS form, except 6 women, recovered after delivery (3rd histogram). Fifty nine of the same pregnancy-related RLS group suffered again RLS symptoms during a further following pregnancy. After a mean follow up of 7 years, 25 out of the 101 women who experienced the symptoms during the first pregnancy (pregnancy-related RLS group) developed a chronic apparently idiopathic RLS form even out of pregnancy. Elaborated data from the study of Cesnik et al.37

View Within ArticleFig. 2. Prevalence of RLS among women in two age groups and according to number of children born in the German general practioner study.43

View Within ArticleFig. 3. Median serum ferritin by age for major USA gender and population groups.

View Within ArticleFig. 4. Prevalence of clinically significant RLS by gender and age from large European and United States population-based samples. (Slightly modified from Allen et al).21

View Within ArticleTable 1. Studies on the prevalence of RLS performed in random samples of the general population of different countries, using the IRLSSG criteria to assess the diagnosis.

View Within ArticleTable 2. Epidemiological studies published in literature on RLS prevalence that included an assessment on the quality of life.

Abbreviations: EQ-5D VAS, visual analogue scale score for the EQ-5D, a quality of life questionnaire developed by the EuroQoL Group; HRQoL, health related quality of life; MCS, mental component score of the SF-36; RLS, restless legs syndrome; PCS, physical component score of the SF-36; SF-36, SF-12, short form health survey.

View Within ArticleTable 3. Studies exploring the role of estrogens in RLS.

Abbreviations: AC, active controlled; CO, crossover; DB, double blind; HRT, hormone replacement therapy; IQR, interquartile range; PC, placebo controlled; PG, parallel group; PLM, periodic leg movements; R, randomized; SD, standard deviation.

View Within ArticleCopyright © 2011 Elsevier Ltd. All rights reserved.

prs.rt('data_end');

View the original article here

When gender matters: Restless legs syndrome. Report of the “RLS and woman” workshop endorsed by the European RLS Study Group

Mauro Manconia, , , Jan Ulfbergb, Klaus Bergerc, Imad Ghorayebd, Jan Wesströme, Stephany Fuldaf, Richard P. Alleng, Thomas Pollmächerf, ha Sleep and Epilepsy Center, Neurocenter (EOC) of Southern Switzerland, Civic Hospital, Lugano, Via Tesserete 46, 6900 Lugano, Switzerlandb Department of Medicine, Uppsala University, Uppsala, Swedenc Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germanyd Clinical Neurophysiology Department, Centre Hospitalier et Universitaire de Bordeaux, Bordeaux cedex, Francee Center for Clinical Research Dalarna, Department of Women's and Children's Health, Uppsala University, Swedenf Max Planck Institute of Psychiatry, Munich, Germanyg Center of Mental Health, Klinikum Ingolstadt, Ingolstadt, Germanyh Department of Neurology, Johns Hopkins University, Bayview Medical Center, Baltimore, MD, USAReceived 13 May 2011. Revised 30 August 2011. Accepted 30 August 2011. Available online 9 November 2011.View full text Sleep is an essential human behavior that shows prominent gender differences. Disturbed sleep, in particular, is much more prevalent in females than males. Restless legs syndrome (RLS) as one cause of disturbed sleep was observed to be somewhat more common among women than men in Ekbom's 1945 seminal series of clinical cases with the disease. He, however, reported this gender difference mainly for those with more severe symptoms. Since then numerous studies have reported that women are affected by RLS about twice as often as males for mild as well as moderate to severe RLS. The present review focuses on RLS in females from the perspectives of both epidemiology and pathophysiology. RLS will generally become worse or might appear for the first time during pregnancy. Parity increases the risk of RLS later in life suggesting that pregnancy is a specific behavioral risk factor for developing RLS. Some evidence suggests that dysfunction in iron metabolism and high estrogen levels might contribute to RLS during pregnancy. But, menopause does not lower the incidence of RLS nor does hormone replacement therapy lead to an increase, suggesting a quite complex uncertain role of hormones in the pathophysiology of RLS. Therefore, further, preferably longitudinal studies are needed to unravel the factors causing RLS in women. These studies should include genetic, clinical and polysomnographic variables, as well as hormonal measures and variables assessing iron metabolism.

prs.rt("abs_end");Restless legs syndrome; Gender; Female; Sleep; Insomnia; Pregnancy; Estrogens; Menopause; Quality of life

Figures and tables from this article:

Fig. 1. Epidemiological results on RLS and pregnancy. Histograms show the prevalence trend of RLS in a group of 606 women surveyed at the end of pregnancy. In the period before pregnancy, 60 women already experienced RLS symptoms in their life (in a non pregnancy period) and were classified as “pre-existing RLS”. The remaining 546 women had never experienced RLS symptoms before and were classified as “healthy”. During the first assessed pregnancy (2nd histogram) 101 women, out of the 546 “healthy” ones, developed a transient RLS form strictly related to the pregnancy and were classified as “pregnancy-related RLS”. All these 101 women with a new form of pregnancy-related RLS form, except 6 women, recovered after delivery (3rd histogram). Fifty nine of the same pregnancy-related RLS group suffered again RLS symptoms during a further following pregnancy. After a mean follow up of 7 years, 25 out of the 101 women who experienced the symptoms during the first pregnancy (pregnancy-related RLS group) developed a chronic apparently idiopathic RLS form even out of pregnancy. Elaborated data from the study of Cesnik et al.37

View Within ArticleFig. 2. Prevalence of RLS among women in two age groups and according to number of children born in the German general practioner study.43

View Within ArticleFig. 3. Median serum ferritin by age for major USA gender and population groups.

View Within ArticleFig. 4. Prevalence of clinically significant RLS by gender and age from large European and United States population-based samples. (Slightly modified from Allen et al).21

View Within ArticleTable 1. Studies on the prevalence of RLS performed in random samples of the general population of different countries, using the IRLSSG criteria to assess the diagnosis.

View Within ArticleTable 2. Epidemiological studies published in literature on RLS prevalence that included an assessment on the quality of life.

Abbreviations: EQ-5D VAS, visual analogue scale score for the EQ-5D, a quality of life questionnaire developed by the EuroQoL Group; HRQoL, health related quality of life; MCS, mental component score of the SF-36; RLS, restless legs syndrome; PCS, physical component score of the SF-36; SF-36, SF-12, short form health survey.

View Within ArticleTable 3. Studies exploring the role of estrogens in RLS.

Abbreviations: AC, active controlled; CO, crossover; DB, double blind; HRT, hormone replacement therapy; IQR, interquartile range; PC, placebo controlled; PG, parallel group; PLM, periodic leg movements; R, randomized; SD, standard deviation.

View Within ArticleCopyright © 2011 Elsevier Ltd. All rights reserved.

prs.rt('data_end');

View the original article here

When gender matters: Restless legs syndrome. Report of the “RLS and woman” workshop endorsed by the European RLS Study Group

Mauro Manconia, , , Jan Ulfbergb, Klaus Bergerc, Imad Ghorayebd, Jan Wesströme, Stephany Fuldaf, Richard P. Alleng, Thomas Pollmächerf, ha Sleep and Epilepsy Center, Neurocenter (EOC) of Southern Switzerland, Civic Hospital, Lugano, Via Tesserete 46, 6900 Lugano, Switzerlandb Department of Medicine, Uppsala University, Uppsala, Swedenc Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germanyd Clinical Neurophysiology Department, Centre Hospitalier et Universitaire de Bordeaux, Bordeaux cedex, Francee Center for Clinical Research Dalarna, Department of Women's and Children's Health, Uppsala University, Swedenf Max Planck Institute of Psychiatry, Munich, Germanyg Center of Mental Health, Klinikum Ingolstadt, Ingolstadt, Germanyh Department of Neurology, Johns Hopkins University, Bayview Medical Center, Baltimore, MD, USAReceived 13 May 2011. Revised 30 August 2011. Accepted 30 August 2011. Available online 9 November 2011.View full text Sleep is an essential human behavior that shows prominent gender differences. Disturbed sleep, in particular, is much more prevalent in females than males. Restless legs syndrome (RLS) as one cause of disturbed sleep was observed to be somewhat more common among women than men in Ekbom's 1945 seminal series of clinical cases with the disease. He, however, reported this gender difference mainly for those with more severe symptoms. Since then numerous studies have reported that women are affected by RLS about twice as often as males for mild as well as moderate to severe RLS. The present review focuses on RLS in females from the perspectives of both epidemiology and pathophysiology. RLS will generally become worse or might appear for the first time during pregnancy. Parity increases the risk of RLS later in life suggesting that pregnancy is a specific behavioral risk factor for developing RLS. Some evidence suggests that dysfunction in iron metabolism and high estrogen levels might contribute to RLS during pregnancy. But, menopause does not lower the incidence of RLS nor does hormone replacement therapy lead to an increase, suggesting a quite complex uncertain role of hormones in the pathophysiology of RLS. Therefore, further, preferably longitudinal studies are needed to unravel the factors causing RLS in women. These studies should include genetic, clinical and polysomnographic variables, as well as hormonal measures and variables assessing iron metabolism.

prs.rt("abs_end");Restless legs syndrome; Gender; Female; Sleep; Insomnia; Pregnancy; Estrogens; Menopause; Quality of life

Figures and tables from this article:

Fig. 1. Epidemiological results on RLS and pregnancy. Histograms show the prevalence trend of RLS in a group of 606 women surveyed at the end of pregnancy. In the period before pregnancy, 60 women already experienced RLS symptoms in their life (in a non pregnancy period) and were classified as “pre-existing RLS”. The remaining 546 women had never experienced RLS symptoms before and were classified as “healthy”. During the first assessed pregnancy (2nd histogram) 101 women, out of the 546 “healthy” ones, developed a transient RLS form strictly related to the pregnancy and were classified as “pregnancy-related RLS”. All these 101 women with a new form of pregnancy-related RLS form, except 6 women, recovered after delivery (3rd histogram). Fifty nine of the same pregnancy-related RLS group suffered again RLS symptoms during a further following pregnancy. After a mean follow up of 7 years, 25 out of the 101 women who experienced the symptoms during the first pregnancy (pregnancy-related RLS group) developed a chronic apparently idiopathic RLS form even out of pregnancy. Elaborated data from the study of Cesnik et al.37

View Within ArticleFig. 2. Prevalence of RLS among women in two age groups and according to number of children born in the German general practioner study.43

View Within ArticleFig. 3. Median serum ferritin by age for major USA gender and population groups.

View Within ArticleFig. 4. Prevalence of clinically significant RLS by gender and age from large European and United States population-based samples. (Slightly modified from Allen et al).21

View Within ArticleTable 1. Studies on the prevalence of RLS performed in random samples of the general population of different countries, using the IRLSSG criteria to assess the diagnosis.

View Within ArticleTable 2. Epidemiological studies published in literature on RLS prevalence that included an assessment on the quality of life.

Abbreviations: EQ-5D VAS, visual analogue scale score for the EQ-5D, a quality of life questionnaire developed by the EuroQoL Group; HRQoL, health related quality of life; MCS, mental component score of the SF-36; RLS, restless legs syndrome; PCS, physical component score of the SF-36; SF-36, SF-12, short form health survey.

View Within ArticleTable 3. Studies exploring the role of estrogens in RLS.

Abbreviations: AC, active controlled; CO, crossover; DB, double blind; HRT, hormone replacement therapy; IQR, interquartile range; PC, placebo controlled; PG, parallel group; PLM, periodic leg movements; R, randomized; SD, standard deviation.

View Within ArticleCopyright © 2011 Elsevier Ltd. All rights reserved.

prs.rt('data_end');

View the original article here

Test group b strep

By Mayo Clinic staff

Group B Streptococcus — also called Group B streptococci — is a common bacterium often carried in the gut or lower genital tract. Although Group b streptococci are usually harmless in adults, can cause pregnancy complications and serious illness in infants. If you are pregnant, health care provider will recommend probably a test group b strep during the third quarter.

During a group b strep test, health care provider will buffer your vagina and rectum and send the samples to a laboratory for testing. In some cases, you may be given instructions on how to collect the samples alone. Because it can occur in certain positive and negative moments at other times, it is necessary to repeat that the Group b strep test whenever you are pregnant.

If the test group b strep is negative, no action is required. If the strep test group b is positive, you will be given antibiotics during labor to prevent disease Group b strep in your child.

Refers to Puopolo KM, et al., infection with Group b strep in pregnant women. http://www.uptodate.com/index. The 29 December 2011. Puopolo KM, et al., infection with Group b Streptococcus in young children and infants. http://www.uptodate.com/index. Accessed 29 December 2011. pregnancy and Group b Streptococcus. American College of Obstetricians and Gynecologists. http://www.ACOG.org/~/media/for%20Patients/faq105.ashx?DMC = TS = 1 & 20111229T1430272285. Accessed on 29 December, 2011. Group B strep (GBS): prevention in infants. Centers for Disease Control and Prevention. http://www.cdc.gov/groupbstrep/about/prevention.html. Accessed 29 December 2011. Centers for disease prevention and control. Prevention of perinatal Group B Streptococcal Disease: revised guidelines from CDC, 2010. MMWR. 2010; 59 (Cod. RR-10): 1. http://www.cdc.gov/MMWR/Preview/mmwrhtml/rr5910a1.htm. The 29 December 2011. Murry MM (expert opinion). Mayo Clinic, Rochester, Minnesota February 24, 2012.

 

Test group b strep

By Mayo Clinic staff

Group B Streptococcus — also called Group B streptococci — is a common bacterium often carried in the gut or lower genital tract. Although Group b streptococci are usually harmless in adults, can cause pregnancy complications and serious illness in infants. If you are pregnant, health care provider will recommend probably a test group b strep during the third quarter.

During a group b strep test, health care provider will buffer your vagina and rectum and send the samples to a laboratory for testing. In some cases, you may be given instructions on how to collect the samples alone. Because it can occur in certain positive and negative moments at other times, it is necessary to repeat that the Group b strep test whenever you are pregnant.

If the test group b strep is negative, no action is required. If the strep test group b is positive, you will be given antibiotics during labor to prevent disease Group b strep in your child.

Refers to Puopolo KM, et al., infection with Group b strep in pregnant women. http://www.uptodate.com/index. The 29 December 2011. Puopolo KM, et al., infection with Group b Streptococcus in young children and infants. http://www.uptodate.com/index. Accessed 29 December 2011. pregnancy and Group b Streptococcus. American College of Obstetricians and Gynecologists. http://www.ACOG.org/~/media/for%20Patients/faq105.ashx?DMC = TS = 1 & 20111229T1430272285. Accessed on 29 December, 2011. Group B strep (GBS): prevention in infants. Centers for Disease Control and Prevention. http://www.cdc.gov/groupbstrep/about/prevention.html. Accessed 29 December 2011. Centers for disease prevention and control. Prevention of perinatal Group B Streptococcal Disease: revised guidelines from CDC, 2010. MMWR. 2010; 59 (Cod. RR-10): 1. http://www.cdc.gov/MMWR/Preview/mmwrhtml/rr5910a1.htm. The 29 December 2011. Murry MM (expert opinion). Mayo Clinic, Rochester, Minnesota February 24, 2012.

 

Test group b strep

By Mayo Clinic staff

Group B Streptococcus — also called Group B streptococci — is a common bacterium often carried in the gut or lower genital tract. Although Group b streptococci are usually harmless in adults, can cause pregnancy complications and serious illness in infants. If you are pregnant, health care provider will recommend probably a test group b strep during the third quarter.

During a group b strep test, health care provider will buffer your vagina and rectum and send the samples to a laboratory for testing. In some cases, you may be given instructions on how to collect the samples alone. Because it can occur in certain positive and negative moments at other times, it is necessary to repeat that the Group b strep test whenever you are pregnant.

If the test group b strep is negative, no action is required. If the strep test group b is positive, you will be given antibiotics during labor to prevent disease Group b strep in your child.

Refers to Puopolo KM, et al., infection with Group b strep in pregnant women. http://www.uptodate.com/index. The 29 December 2011. Puopolo KM, et al., infection with Group b Streptococcus in young children and infants. http://www.uptodate.com/index. Accessed 29 December 2011. pregnancy and Group b Streptococcus. American College of Obstetricians and Gynecologists. http://www.ACOG.org/~/media/for%20Patients/faq105.ashx?DMC = TS = 1 & 20111229T1430272285. Accessed on 29 December, 2011. Group B strep (GBS): prevention in infants. Centers for Disease Control and Prevention. http://www.cdc.gov/groupbstrep/about/prevention.html. Accessed 29 December 2011. Centers for disease prevention and control. Prevention of perinatal Group B Streptococcal Disease: revised guidelines from CDC, 2010. MMWR. 2010; 59 (Cod. RR-10): 1. http://www.cdc.gov/MMWR/Preview/mmwrhtml/rr5910a1.htm. The 29 December 2011. Murry MM (expert opinion). Mayo Clinic, Rochester, Minnesota February 24, 2012.